Therefore, the subcellular localization of STAT3 directly guides canonical and non-canonical pathways that are involved in tumorigenesis and tumor-induced reprogramming of immune system, highlighting STAT3 as a primary target to build up effective immunotherapeutic strategies. This evidence concerns the gene STAT3 and neoplasm.